Skip to Main Content

Try STAT+ TODAY

Valeant Pharmaceuticals

Most Read

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

Valeant

Pharmalot By Ed Silverman

Feds charge former Valeant and Philidor execs with fraud

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant may change its name to create a new image

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Glaxo CEO looks for drug prices to fall no matter who is president

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant looks to sell Salix to lessen debt load

Valeant

Pharmalot By Ed Silverman

Former Valeant CEO and CFO are being investigated by the feds

Pharmalot By Ed Silverman

Congressman calls for probe into Valeant’s pricing of lead poisoning drug

All Coverage

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Valeant

Pharmalot By Ed Silverman

Valeant avoids double-digit price hikes with 9.9 percent increases

advertisement

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug

Valeant Addyi

Pharmalot By Ed Silverman

Valeant gets poor grades for its Addyi female libido pill

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant under criminal investigation for defrauding insurers

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant reorganizes and maintains earnings forecast

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant overhauls part of its management team

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant losing a crucial revenue tool

Rising drug cost

The Pharmalot View By Ed Silverman

Pharma trade group says price gougers are outliers, but then accepts two more

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA overlooks troubles at Chinese supplier to avoid shortages

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Novartis stops making TB drugs in Pakistan, prompting fear of a health crisis

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA reviewers say Valeant drug carries suicide risks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Medivation to start takeover talks with Sanofi and others

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: India inspects 200 drug makers for poor-quality meds